Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 12:12 pm Purchase | 2025-06-30 | 13G | Ascendis Pharma A/S ASND | T. Rowe Price Investment Management, Inc. | 3,583,546 6.400% | 529,722 (+17.35%) | Filing History |
| 2025-08-14 10:57 am Sale | 2025-06-30 | 13G | Ascendis Pharma A/S ASND | JANUS HENDERSON GROUP PLC JHG | 4,427,792 8.000% | -69,243 (-1.54%) | Filing History |
| 2025-08-13 12:49 pm Purchase | 2025-06-30 | 13G | Ascendis Pharma A/S ASND | Capital International Investors | 3,109,225 5.600% | 3,109,225 (New Position) | Filing History |
| 2025-05-14 11:59 am Purchase | 2025-03-31 | 13G | Ascendis Pharma A/S ASND | JANUS HENDERSON GROUP PLC JHG | 4,497,035 7.400% | 116,653 (+2.66%) | Filing History |
| 2025-05-14 10:47 am Purchase | 2025-03-31 | 13G | Ascendis Pharma A/S ASND | T. Rowe Price Investment Management, Inc. | 3,053,824 5.000% | 1,288,782 (+73.02%) | Filing History |
| 2025-05-12 10:24 am Sale | 2025-03-31 | 13G | Ascendis Pharma A/S ASND | FMR LLC | 4,646,943 8.000% | -467,426 (-9.14%) | Filing History |
| 2025-02-14 11:54 am Purchase | 2024-12-31 | 13G | Ascendis Pharma A/S ASND | JANUS HENDERSON GROUP PLC JHG | 4,380,382 7.200% | 193,688 (+4.63%) | Filing History |
| 2025-02-11 09:15 am Purchase | 2024-12-31 | 13G | Ascendis Pharma A/S ASND | WESTFIELD CAPITAL MANAGEMENT CO LP | 5,528,239 9.180% | 1,453,025 (+35.66%) | Filing History |
| 2025-02-10 5:13 pm Purchase | 2024-12-31 | 13G | Ascendis Pharma A/S ASND | WESTFIELD CAPITAL MANAGEMENT CO LP | 4,075,214 9.180% | 44,580 (+1.11%) | Filing History |
| 2024-11-14 5:46 pm Sale | 2024-09-30 | 13G | Ascendis Pharma A/S ASND | RA CAPITAL MANAGEMENT L.P. | 9,710,428 16.100% | -396,972 (-3.93%) | Filing History |
| 2024-11-14 2:57 pm Purchase | 2024-09-30 | 13G | Ascendis Pharma A/S ASND | JANUS HENDERSON GROUP PLC JHG | 4,186,694 7.000% | 191,909 (+4.80%) | Filing History |
| 2024-11-14 1:28 pm Sale | 2024-09-30 | 13G | Ascendis Pharma A/S ASND | T. Rowe Price Investment Management, Inc. | 1,765,042 2.900% | -2,224,788 (-55.76%) | Filing History |
| 2024-11-14 09:31 am Purchase | 2024-09-30 | 13G | Ascendis Pharma A/S ASND | Avoro Capital Advisors LLC | 4,988,888 8.200% | 1,233,333 (+32.84%) | Filing History |
| 2024-11-12 09:51 am Sale | 2024-09-30 | 13G | Ascendis Pharma A/S ASND | Artisan Partners Asset Management Inc. | 4,411,111 7.300% | -1,338,116 (-23.27%) | Filing History |
| 2024-11-08 10:34 am Sale | 2024-09-30 | 13G | Ascendis Pharma A/S ASND | Wellington Management Group LLP | 1,261,480 2.210% | -1,986,813 (-61.16%) | Filing History |
| 2024-02-16 4:29 pm Sale | 2023-12-31 | 13G | Ascendis Pharma A/S ASND | T. Rowe Price Associates, Inc. | 1,444,950 2.500% | -9,424,610 (-86.71%) | Filing History |
| 2024-02-14 5:01 pm Purchase | 2023-12-31 | 13G | Ascendis Pharma A/S ASND | RA CAPITAL MANAGEMENT L.P. | 10,107,400 17.500% | 140,228 (+1.41%) | Filing History |
| 2024-02-14 4:21 pm Sale | 2023-12-31 | 13G | Ascendis Pharma A/S ASND | BAKER BROS. ADVISORS LP | 0 0.000% | -4,954,855 (Position Closed) | Filing History |
| 2024-02-14 10:04 am Purchase | 2023-12-31 | 13G | Ascendis Pharma A/S ASND | T. Rowe Price Investment Management, Inc. | 3,989,830 6.900% | 3,989,830 (New Position) | Filing History |
| 2024-02-14 10:03 am Purchase | 2023-12-31 | 13G | Ascendis Pharma A/S ASND | T. Rowe Price Associates, Inc. | 10,869,560 2.500% | 7,159,719 (+192.99%) | Filing History |